A new study from the University of Wisconsin-Madison suggests that chemotherapy may not be reaching its full potential, in part…
A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can…
A new Northwestern Medicine study challenges a common belief in what triggers Parkinson's disease. Degeneration of dopaminergic neurons is widely…
Computer scientists and mathematicians working in complex systems at the University of Sydney and the Max Planck Institute for Mathematics…